Skip to content
New website under construction. Stay tuned!
Insight: Industry Presentations
Calendar of Events
Fill out my
Fill out my Wufoo form!
Nanobiotix presented new clinical and pre-clinical data confirming NBTXR3’s significant potential role in Immuno-Oncology at SITC Annual Meeting
Nanobiotix presents first promising data from Phase I/II Liver Cancers trial of NBTXR3 at the American Society Of Clinical Oncology Gastrointestinal Annual Meeting